Imperva Inc (NYSE:IMPV) had its price target upped by Monness Crespi & Hardt from $55.00 to $57.00 in a research note released on Friday, Marketbeat reports. Monness Crespi & Hardt currently has a buy rating on the software maker’s stock.

Several other research firms have also recently commented on IMPV. Stifel Nicolaus restated a hold rating and set a $47.00 price target on shares of Imperva in a report on Friday, July 14th. Susquehanna Bancshares Inc assumed coverage on shares of Imperva in a report on Wednesday, June 7th. They set a positive rating and a $60.00 price target for the company. UBS AG assumed coverage on shares of Imperva in a report on Tuesday, June 6th. They set a positive rating and a $60.00 price target for the company. Stephens restated an overweight rating and set a $61.00 price target (up from $53.00) on shares of Imperva in a report on Thursday, July 13th. Finally, BidaskClub cut shares of Imperva from a buy rating to a hold rating in a report on Tuesday, July 25th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average target price of $50.39.

Imperva (NYSE:IMPV) opened at 44.90 on Friday. The stock’s market cap is $1.51 billion. The firm’s 50-day moving average is $48.82 and its 200-day moving average is $45.19. Imperva has a 1-year low of $34.40 and a 1-year high of $57.24.

Imperva (NYSE:IMPV) last posted its quarterly earnings results on Thursday, July 27th. The software maker reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.05 by $0.15. The company had revenue of $74.44 million for the quarter, compared to analyst estimates of $74.30 million. Imperva had a return on equity of 36.67% and a net margin of 31.92%. The business’s revenue for the quarter was up 28.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.23) earnings per share. On average, analysts forecast that Imperva will post $0.45 EPS for the current year.

TRADEMARK VIOLATION WARNING: This piece was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://www.watchlistnews.com/monness-crespi-hardt-boosts-imperva-inc-impv-price-target-to-57-00/1465498.html.

In other news, insider Amichai Shulman sold 3,089 shares of the business’s stock in a transaction on Monday, May 15th. The shares were sold at an average price of $48.70, for a total value of $150,434.30. Following the completion of the sale, the insider now directly owns 100,151 shares in the company, valued at $4,877,353.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CRO Michael D. Mooney sold 52,356 shares of the business’s stock in a transaction on Wednesday, May 10th. The stock was sold at an average price of $47.51, for a total transaction of $2,487,433.56. Following the completion of the sale, the executive now owns 52,356 shares of the company’s stock, valued at $2,487,433.56. The disclosure for this sale can be found here. Insiders sold 60,302 shares of company stock valued at $2,875,861 over the last 90 days. 2.20% of the stock is owned by corporate insiders.

Several hedge funds have recently modified their holdings of IMPV. Ameritas Investment Partners Inc. purchased a new stake in shares of Imperva during the first quarter worth $102,000. KCG Holdings Inc. purchased a new stake in shares of Imperva during the first quarter worth $201,000. US Bancorp DE boosted its stake in shares of Imperva by 142.3% in the first quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock worth $221,000 after buying an additional 3,163 shares during the last quarter. Jane Street Group LLC purchased a new stake in shares of Imperva during the first quarter worth $224,000. Finally, Trexquant Investment LP purchased a new stake in shares of Imperva during the first quarter worth $242,000. Institutional investors and hedge funds own 92.72% of the company’s stock.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.